Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Redefining Healthcare: Prioritizing in Remote Patient Monitoring

Remote Patient Monitoring (RPM) is using digital tools to provide care beyond traditional clinical settings, improving patient outcomes and reducing costs. Tools like Tripolo are helping these efforts by integrating technology into smart homes and facilitating personal communication between patients and providers. This shift towards digital solutions in healthcare supports patient independence and caters to those with chronic conditions or who are aging in place.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Healthcare ·
Share
Redefining Healthcare: Prioritizing in Remote Patient Monitoring

Key takeaways

01

Remote Patient Monitoring (RPM) improves patient care by leveraging digital tools outside of traditional clinical settings.

02

Clinically validated and affordable digital tools enable effective healthcare delivery, particularly for chronic and aging patients.

03

Platforms like Tripolo enhance healthcare accessibility by integrating RPM with smart home technology.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

This report underscores the potential of remote patient monitoring (RPM) as a breakthrough element in patient-centric healthcare. It discusses the incorporation of digital technology for monitoring patients outside of clinical settings, with various affordable, clinically validated tools playing a vital role in improving patient outcomes. The report draws on industry-leading platforms, such as Tripolo and their customized offerings, providing insights into the overarching impact of RPM in healthcare.

Introduction

Reflecting the strategic emphasis on patient independence and improved clinical outcomes, this case study explores evolving RPM technology, particularly for chronic and aging patients. By analyzing the application of these digital tools and their contribution to the healthcare landscape, we assess their relevance in democratizing patient care.

Findings

For patients experiencing chronic conditions or aging in place, conventional in-person care is often impractical. Herein lies the value of RPM that allows effective monitoring outside of clinical settings. The effectiveness of such monitoring is contingent on the accuracy of the technology, highlighting the importance of clinically validated tools. Integrating these tools into smart connected homes paves the way for cost-effective and convenient healthcare solutions.

Discussion

A shift towards patient independence and improved clinical outcomes necessitates an exploration of alternative solutions. One viable alternative is the consolidation of smart connected healthcare tools with smart homes, encouraging affordable and convenient home-bound patient care. As a testament to the potential of this digital transformation, platforms like Tripolo are ameliorating healthcare accessibility by facilitating personalized patient-provider communication.

Leveraging affordable and clinically validated tools not only reinvents the provision of healthcare but also attunes it to the changing needs of patients, particularly those with chronic conditions or aging in place.

Conclusion

The value of integrating digital tools in RPM is readily apparent in facilitating patient care. Leveraging affordable and clinically validated tools not only reinvents the provision of healthcare but also attunes it to the changing needs of patients, particularly those with chronic conditions or aging in place.

Recommendations

Healthcare professionals should pivot towards adopting digital tools for RPM, placing emphasis on patient-centric care, clinical validation, and affordability of these tools. Platforms like Tripolo can serve as an effective starting point for this transformation. Continuous assessment and improvement of these technological applications will ensure their sustained relevance in improving patient outcomes.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512